UroGen Pharma Ltd. (URGN)

SEC filing

UroGen Pharma Ltd.

URGN · CIK 1668243

4 · Sep 9, 2026 · Chief Medical Officer Schoenberg Mark sold 871 shares at $42.92/share ($37,383); exercised options for 1,667 shares

Chief Medical Officer Schoenberg Mark sold 871 shares at $42.92/share ($37,383); exercised options for 1,667 shares

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).